To drive performance for CABLIVI and the upcoming launch of Hemophilia medication, build and maintain strong business partnerships with key stakeholders and ensure accessibility in key accounts in Western Province and remote regions. Develop and maintain relationships with thought leaders, presenting information and marketing new therapeutic products to physicians and other healthcare professionals to ensure sales and patient identification numbers are met.
To achieve success, it is critical that the KAM Specialty Care:
KEY RESULTS / ACCOUNTABILITIES
1. Pre-launch Responsibilities
Hemophilia:
2. Post Launch Responsibilities Cablivi & Haemophilia TA
Maintain compliance
Abide by the requirements of the internal Code of Ethics including but not restricted to maintaining high professional standards of conduct in line with the Company procedure with a duty of care to the reputation of the Company.